Enliven Therapeutics (ELVN) Preferred Shares Issued (2019 - 2020)

Enliven Therapeutics has disclosed Preferred Shares Issued across 2 years of filings, most recently posting $17.2 million for Q1 2020.

• Preferred Shares Issued for Q1 2020 came in at $17.2 million, down 60.96% year-over-year; the trailing twelve-month figure through Dec 2020 was $17.2 million (down 62.37% YoY), and the FY2020 annual result was $17.2 million, down 62.37% from the prior year.
• Preferred Shares Issued came in at $17.2 million for Q1 2020 at Enliven Therapeutics, up from $1.6 million in the prior quarter.
• In the past five years, Preferred Shares Issued ranged from a high of $43.9 million in Q1 2019 to a low of $1.6 million in Q2 2019.